Fulcrum Therapeutics News

Latest Fulcrum Therapeutics Stock News & FULC Headlines

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Stock Has Average Target Price of $8.20

a month ago | defenseworld.net

Kaplan Fox is Investigating Claims Against Fulcrum Therapeutics, Inc. (FULC) on Behalf of Investors

a month ago | newsfilecorp.com

Kaplan Fox Encourages Fulcrum Therapeutics, Inc. (FULC) Investors Who Suffered Losses to Learn About Their Legal Rights

a month ago | newsfilecorp.com

Kaplan Fox Investor Alert: Fulcrum Therapeutics, Inc. (FULC) Investigated for Possible Securities Law Violations

a month ago | newsfilecorp.com

Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (FULC) and its Board for Possible Securities Law Violations

2 months ago | newsfilecorp.com

Kaplan Fox Notifies Fulcrum Therapeutics, Inc. (FULC) Investors of a Pending Securities Investigation

2 months ago | newsfilecorp.com

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Rating of “Reduce” from Brokerages

2 months ago | defenseworld.net

Kaplan Fox Alerts Fulcrum Therapeutics, Inc. (FULC) Investors: The Firm is Investigating Possible Securities Law Violations

2 months ago | newsfilecorp.com

Kaplan Fox Broadens its Investigation of Fulcrum Therapeutics, Inc. (FULC) for Possible Securities Law Violations

2 months ago | newsfilecorp.com

Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (FULC) to Learn More About the Firm's Investigation

2 months ago | newsfilecorp.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

FULC

Fulcrum Therapeutics

$ 3.77

2.45%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Fulcrum Therapeutics News

Latest Fulcrum Therapeutics Stock News & FULC Headlines

Download App

People Also Watch

Explore our Tools